Inventor · disambiguated record
Amelia Black
Also filed as: BLACK AMELIA · BLACK AMELIA NANCY
14 granted patents·7 pending applications·502 citations·filing 1995–2012
94Inventor score
Top patents by PatentIndex Score
21 records- 0198US7910798B2Transgenic animals expressing chimeric antibodies for use in preparing human antibodiesMEDAREX INC·Filed 2007·Granted Mar 22, 2011·130 cites·5 claims
- 0296US6001358AHumanized antibodies to human gp39, compositions containing thereofIDEC PHARMA CORP·Filed 1995·Granted Dec 14, 1999·125 cites·12 claims
- 0395US8232449B2Transgenic animals expressing chimeric antibodies for use in preparing human antibodiesTANAMACHI DAWN M·Filed 2011·Granted Jul 31, 2012·33 cites·8 claims
- 0493US6733763B2Induction of cytotoxic T-lymphocyte responsesBIOGEN IDEC INC·Filed 2000·Granted May 11, 2004·39 cites·19 claims
- 0588US8207303B2Monoclonal antibodies against CD30 lacking in fucosyl residuesCARDARELLI JOSEPHINE M·Filed 2006·Granted Jun 26, 2012·11 cites·13 claims
- 0687US5695770AInduction of cytotoxic T-lymphocyte responsesIDEC PHARMA CORP·Filed 1995·Granted Dec 9, 1997·74 cites·9 claims
- 0785US7122187B2Treating autoimmune diseases with humanized anti-CD40L antibodyBIOGEN IDEC INC·Filed 2002·Granted Oct 17, 2006·23 cites·8 claims
- 0885US7074406B2Treating allergic diseases with humanized anti-CD40L antibodyBIOGEN IDEC INC·Filed 2002·Granted Jul 11, 2006·14 cites·9 claims
- 0980US6440418B1Methods of treating autoimmune diseases with gp39-specific antibodiesIDEC PHARMA CORP·Filed 1997·Granted Aug 27, 2002·36 cites·16 claims
- 1073US9220244B2Transgenic animals expressing chimeric antibodies for use in preparing human antibodiesTANAMACHI DAWN M·Filed 2012·Granted Dec 29, 2015·1 cites·8 claims
- 1170US8491898B2Monoclonal antibodies against CD30 lacking in fucosyl residuesCARDARELLI JOSEPHINE M·Filed 2012·Granted Jul 23, 2013·1 cites·16 claims
- 1269US7674618B2Expression vectorMEDAREX INC·Filed 2004·Granted Mar 9, 2010·1 cites·17 claims
- 1364US2006057162A1Induction of cytotoxic T-lymphocyte responsesBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 1459US2006147446A1Humanized antibodies to human GP39, compositions, and therapeutic uses thereofBLACK AMELIA·Filed 2006·Application pending·0 cites
- 1558US6506383B1Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodiesIDEC PHARMA CORP·Filed 1999·Granted Jan 14, 2003·9 cites·27 claims
- 1656US2006153837A1Treating autoimmune diseases with humanized anti-CD401 antibodiesBLACK AMELIA·Filed 2006·Application pending·0 cites
- 1750US2010104564A1Altered Antibody Fc Regions and Uses ThereofHANSEN GENEVIEVE·Filed 2006·Application pending·0 cites
- 1850US2011123440A1Altered Antibody FC Regions and Uses ThereofHANSEN GENEVIEVE·Filed 2006·Application pending·0 cites
- 1950US2012276086A1Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residuesBLACK AMELIA NANCY·Filed 2012·Application pending·0 cites
- 2049US2004197331A1Induction of cytotoxic T-lymphocyte responsesBIOGEN IDEC INC·Filed 2003·Application pending·0 cites
- 2138US6197311B1Induction of cytotoxic T-lymphocyte responsesIDEC PHARMA CORP·Filed 1998·Granted Mar 6, 2001·5 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Amelia Black files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →